|Last Price||Today's Change||52-Week Range||Trading Volume|
|57.76||0.00 (0.00%)||44.03 - 60.02||296.3 thousand (Below Avg)|
Market data as of 12:00AM 09/30/14. Quotes are delayed by at least 15 min.
AbbVie Presents Results from Multiple Studies of Investigational Compound Veliparib in Patients with Non-Small Cell Lung Cancer at the European Society for Medical Oncology Annual Congress
09/27/2014 6:45 AM ET